Hamilton, ON, Nov. 14, 2024, In a groundbreaking study, researchers at McMaster University have identified a potential ...

NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (" NurExone " or the " Company "), a biopharmaceutical company developing exosome-based regenerative therapies, is pleased to announce ...

Regular exercise, good nutrition, and a balanced diet. All are vital components of overall health. But did you know that what ...

The Western medical establishment ousted him. China embraced him. Will the man on a mission to perform the first human head ...

The agreement will also help advance NLS’s platform of dual orexin receptor agonists (DOXA) for a number of brain conditions.

around nerve fibers in the central nervous system (brain and spinal cord). This damage disrupts communication between the ...

Through brain implants, neural interfaces and skin grafts, researchers are starting to restore sensation for paralysed or ...

Walking with sciatica is not as straightforward as walking without sciatica. Find out how to walk in a way that's good for ...

Final CMS rule concludes iovera is a qualifying device for separate payment under the NOPAIN Act ---- Beginning January 1, 2025, providers can ...

Long-term treatment with the cell therapy NurOwn was found to significantly extend survival for ALS patients compared with ...

From technologies to payer systems, many aspects of spine surgery and care that promise benefits could be causing more trouble instead.

Approval number: J-20200105. Prior to the publication of this study ... 3.C7 superior articular process, 4.C7 spinal nerve, 5.Spinal ganglia, 6. anterior root of C7 nerve, 7.posterior root of C7 nerve ...